In general, manufacture of medicine has demerit of long period in investment effect, high risk, expensiveness through new drug development. At empirical test, R&D investment for new drug development positively affects on profit in manufacture of medicine. In Korea, effect on R&D investment in manufacture of medicine occur faster than previous period. Manufacture of medicine is value added industry, compared to other industries. Moreover, U.S & Japan in R&D expenditure on sales respectively has 10.1%, 8.07%. This is 3-4 times, compared to R&D expenditure on sales of Korea. Conclusionally, the importance of R&D investment increase more and more in future. So, manufacture of medicine and Companies related this will care for R&D investment.

Abstract
 1. 서론
 2. 미국 : 가장 높은 R&D 투자 산업
  2.1. R&D 투자의 성장 추세
 3. 한국 : R&D 투자가 완만하지만 증가추세
  3.1. R&D 투자의 성장 추세
  3.2. 제약산업의 R&D 투자 효과분석
 4. 요약 및 결론
 5. 참고문헌

• 김종권